1 |
Mhaidly R, Mechta-Grigoriou F. Role of cancer-associa-ted fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer[J]. Immunol Rev, 2021, 302(1): 259-272.
|
2 |
Vennin C, Mélénec P, Rouet R, et al. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan[J]. Nat Commun, 2019, 10(1): 3637.
|
3 |
Gao L, Morine Y, Yamada S, et al. The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts[J]. Cancer Sci, 2021, 112(9): 3545-3554.
|
4 |
McAndrews KM, Chen Y, Darpolor JK, et al. Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct IL6-mediated therapy resistance in pancreatic cancer[J]. Cancer Discov, 2022, 12(6): 1580-1597.
|
5 |
Huang C, Liu J, He L, et al. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development[J]. Bioengineered, 2021, 12(2): 11738-11755.
|
6 |
Espinosa CA, Fernández-Valle Á, Lequerica-Fernández P, et al. Clinicopathologic and surgical study of pleomorphic adenoma of the parotid gland: analysis of risk factors for recurrence and facial nerve dysfunction[J]. J Oral Maxillofac Surg, 2018, 76(2): 347-354.
|
7 |
Rooker SA, Van Abel KM, Yin LX, et al. Risk factors for subsequent recurrence after surgical treatment of recurrent pleomorphic adenoma of the parotid gland[J]. Head Neck, 2021, 43(4): 1088-1096.
|
8 |
Tang T, Huang X, Zhang G, et al. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy[J]. Signal Transduct Target Ther, 2021, 6(1): 72.
|
9 |
Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives[J]. Mol Cancer, 2021, 20(1): 131.
|
10 |
Geng X, Chen H, Zhao L, et al. Cancer-associated fibroblast (CAF) geterogeneity and targeting therapy of CAFs in pancreatic cancer[J]. Front Cell Dev Biol, 2021, 9: 655152.
|
11 |
Zhou B, Chen WL, Wang YY, et al. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma[J]. J Oral Pathol Med, 2014, 43(8): 585-592.
|
12 |
王淑淑, 崔镓钰, 张凯佳, 等. SP13786通过CAFs外泌体抑制Stat3-EMT影响肺腺癌细胞A549的迁移侵袭 [J]. 中国肺癌杂志, 2021, 24(6): 384-393.
|
|
Wang SS, Cui JY, Zhang KJ, et al. SP13786 inhibits the migration and invasion of lung adenocarcinoma cell A549 by supressing Stat3-EMT via CAFs exosomes[J]. Chin J Lung Cancer, 2021, 24(6): 384-393.
|
13 |
席磊, 付立新, 唐曦, 等. 癌相关成纤维细胞miR-200c 对乳腺癌细胞侵袭的影响[J]. 基因组学与应用生物学, 2018, 37(6): 2708-2713.
|
|
Xi L, Fu LX, Tang X, et al. Effect of miR-200c in cancer-associated fibroblast on the invasion of human breast cancer cells[J]. Genom Appl Biol, 2018, 37(6): 2708-2713.
|
14 |
Spaeth EL, Dembinski JL, Sasser AK, et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression[J]. PLoS One, 2009, 4(4): e4992.
|
15 |
Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis[J]. Rom J Morphol Embryol, 2018, 59(2): 455-467.
|